Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus

van der Linden, J.W.M.; Arendrup, M.C.; Warris, A.; Lagrou, K.; Pelloux, H.; Hauser, P.M.; Chryssanthou, E.; Mellado, E.; Kidd, S.E.; Tortorano, A.M.; Dannaoui, E.; Gaustad, P.; Baddley, J.W.; Uekötter, A.; Lass-Flörl, C.; Klimko, N.; Moore, C.B.; Denning, D.W.; Pasqualotto, A.C.; Kibbler, C.; Arikan-Akdagli, S.; Andes, D.; Meletiadis, J.; Naumiuk, L.; Nucci, M.; Melchers, W.J.G.; Verweij, P.E.

doi:10.3201/eid2106.140717

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus

Published Date:

Jun 2015

Publisher's site:

http://dx.doi.org/10.3201/eid2106.140717 New Site Icon

Source:

Emerg Infect Dis. 21(6):1041-1044.

[PDF-816.13 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

van der Linden, J.W.M. ; Arendrup, M.C. ; Warris, A. ; Lagrou, K. ; Pelloux, H. ; ... More ▼

Description:

To investigate azole resistance in clinical Aspergillus isolates, we conducted prospective multicenter international surveillance. A total of 3,788 Aspergillus isolates were screened in 22 centers from 19 countries. Azole-resistant A. fumigatus was more frequently found (3.2% prevalence) than previously acknowledged, causing resistant invasive and noninvasive aspergillosis and severely compromising clinical use of azoles.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	license.txt	text/plain
	14-0717-F1.gif	image/gif
	14-0717-F1.jpg	image/jpeg
	14-0717-F2.gif	image/gif
	14-0717-F2.jpg	image/jpeg
	14-0717-Techapp-s1.pdf	application/pdf
	14-0717.nxml	text/plain

No Related Documents.

You May Also Like:

Multiple Fungicide-Driven Alterations in Azole-Resistant Aspergillus fumigatus, Colombia, 2015

Personal Author:

Le Pape, Patrice; Lavergne, Rose-Anne; Morio, Florent; Alvarez-Moreno, Carlos;

Published Date:

Jan 2016

Source:

Emerg Infect Dis. 22(1):156-157.

File Type:

[PDF - 266.82 KB]
Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007–2009

Personal Author:

van der Linden, Jan W.M.; Snelders, Eveline; Kampinga, Greetje A.; Rijnders, Bart J.A.; Mattsson, Eva; Debets-Ossenkopp, Yvette J.; Van Tiel, Frank H.; Melchers, Willem J.G.; Verweij, Paul E.;

Corporate Authors:

Kuijper

Published Date:

Oct 2011

Source:

Emerg Infect Dis. 17(10):1846-1854.

Description:

The prevalence and spread of azole resistance in clinical Aspergillus fumigatus isolates in the Netherlands are currently unknown. Therefore, we performed a prospective nationwide multicenter surveillance study to determine the effects of resistance ...

File Type:

[PDF - 279.34 KB]
Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis

Personal Author:

Alanio, Alexandre; Denis, Blandine; Hamane, Samia; Raffoux, Emmanuel; Peffault de Latour, Régis; Menotti, Jean; Amorim, Sandy; Touratier, Sophie; Bergeron, Anne; Bretagne, Stéphane;

Published Date:

Jan 2016

Source:

Emerg Infect Dis. 22(1):157-158.

File Type:

[PDF - 266.31 KB]
Anticipated Negative Responses by Students to Possible Ebola Virus Outbreak, Guangzhou, China

Personal Author:

Lau, Joseph T.F.; Wang, Zixin; Kim, Yoona; Gu, Jing; Wu, Anise M.S.; Zhou, Qianling; Hao, Chun; Cheng, Perry; Hao, Yuantao;

Published Date:

Jan 2016

Source:

Emerg Infect Dis. 22(1):154-156.

File Type:

[PDF - 319.01 KB]
Multidrug-Resistant Aspergillus fumigatus Carrying Mutations Linked to Environmental Fungicide Exposure — Three States, 2010–2017

Personal Author:

Beer, Karlyn D.; Farnon, Eileen C.; Jain, Seema; Jamerson, Carol; Lineberger, Sarah; Miller, Jeffrey; Berkow, Elizabeth L.; Lockhart, Shawn R.; Chiller, Tom; Jackson, Brendan R.;

Published Date:

Sep 28 2018

Source:

MMWR Morb Mortal Wkly Rep. 67(38):1064-1067.

Description:

The environmental mold Aspergillus fumigatus is the primary cause of invasive aspergillosis. In patients with high-risk conditions, including stem cell and organ transplant recipients, mortality exceeds 50%. Triazole antifungals have greatly improved...

File Type:

[PDF - 209.26 KB]